Tapewire

Nasdaq · USD

GILD

GILEAD SCIENCES, INC.

Export transactions ↓
Tapewire entity
405
SEC CIK
0000882095
Parsed reports
2,002

Last 12 months

Inside the activity.

0 purchase rows · 75 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 2025011
Dec 202503
Jan 202606
Feb 202608
Mar 202603
Apr 202604
May 202605
Jun 202607
Jul 202604
Aug 2026015
Sep 202607
Oct 202602

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
January 26, 2021 Filed Jan 29, 2021 00:45 UTC
Dickinson Andrew DEVP, Chief Financial Officer
GrantCommon Stock 12,914 $0.00 $0.00
Disclosure

SEC source: 0001127602-21-002910 · form4.xml · nonDerivative · entry 1

Dickinson Andrew D · CIK 0001310204 · EVP, Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 29,200

F1 · shares: Represents shares of the Issuer's common stock subject to specific tranches of the performance share awards made to the Reporting Person on February 6, 2019, and March 10, 2020. Such tranches of shares were subject to both performance-vesting and service-vesting requirements. The performance vesting requirement was satisfied on the date reported in Column 2 above upon certification of performance goal attainment by the Compensation and Talent Committee of the Issuer's Board of Directors. However, the shares will not be issued to the Reporting Person until the requisite continuing service requirements are also met.

Read SEC document
January 26, 2021 Filed Jan 29, 2021 00:52 UTC
O'Day Daniel PatrickDirector · Chairman & CEO
GrantCommon Stock 59,100 $0.00 $0.00
Disclosure

SEC source: 0001127602-21-002912 · form4.xml · nonDerivative · entry 1

O'Day Daniel Patrick · CIK 0001638643 · Director · Chairman & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 106,670

F1 · shares: Represents shares of the Issuer's common stock subject to specific tranches of the performance share awards made to the Reporting Person on March 1, 2019, and March 10, 2020. Such tranches of shares were subject to both performance-vesting and service-vesting requirements. The performance vesting requirement was satisfied on the date reported in Column 2 above upon certification of performance goal attainment by the Compensation and Talent Committee of the Issuer's Board of Directors. However, the shares will not be issued to the Reporting Person until the requisite continuing service requirements are also met.

Read SEC document
January 26, 2021 Filed Jan 29, 2021 00:57 UTC
Parsey MerdadChief Medical Officer
GrantCommon Stock 9,214 $0.00 $0.00
Disclosure

SEC source: 0001127602-21-002914 · form4.xml · nonDerivative · entry 1

Parsey Merdad · CIK 0001792150 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,899

F1 · shares: Represents shares of the Issuer's common stock subject to specific tranches of the performance share awards made to the Reporting Person on March 10, 2020. Such tranches of shares were subject to both performance-vesting and service-vesting requirements. The performance vesting requirement was satisfied on the date reported in Column 2 above upon certification of performance goal attainment by the Compensation and Talent Committee of the Issuer's Board of Directors. However, the shares will not be issued to the Reporting Person until the requisite continuing service requirements are also met.

Read SEC document
January 26, 2021 Filed Jan 29, 2021 01:04 UTC
Mercier JohannaChief Commercial Officer
GrantCommon Stock 8,068 $0.00 $0.00
Disclosure

SEC source: 0001127602-21-002916 · form4.xml · nonDerivative · entry 1

Mercier Johanna · CIK 0001782135 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,974

F1 · shares: Represents shares of the Issuer's common stock subject to specific tranches of the performance share awards made to the Reporting Person on March 10, 2020. Such tranches of shares were subject to both performance-vesting and service-vesting requirements. The performance vesting requirement was satisfied on the date reported in Column 2 above upon certification of performance goal attainment by the Compensation and Talent Committee of the Issuer's Board of Directors. However, the shares will not be issued to the Reporting Person until the requisite continuing service requirements are also met.

Read SEC document
January 26, 2021 Filed Jan 29, 2021 01:06 UTC
Wilfong Diane E.SVP, Controller & CAO
GrantCommon Stock 1,294 $0.00 $0.00
Disclosure

SEC source: 0001127602-21-002918 · form4.xml · nonDerivative · entry 1

Wilfong Diane E. · CIK 0001374988 · SVP, Controller & CAO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,495

F1 · shares: Represents shares of the Issuer's common stock subject to specific tranches of the performance share awards made to the Reporting Person on February 6, 2019, and March 10, 2020. Such tranches of shares were subject to both performance-vesting and service-vesting requirements. The performance vesting requirement was satisfied on the date reported in Column 2 above upon certification of performance goal attainment by the Compensation and Talent Committee of the Issuer's Board of Directors. However, the shares will not be issued to the Reporting Person until the requisite continuing service requirements are also met.

Read SEC document
January 26, 2021 Filed Jan 29, 2021 01:08 UTC
Pletcher Brett AEVP,Corp Affairs & Gen Counsel
Tax withholdingCommon Stock 3,736 $66.70 $249,191.20
Disclosure

SEC source: 0001127602-21-002920 · form4.xml · nonDerivative · entry 3

Pletcher Brett A · CIK 0001739307 · EVP,Corp Affairs & Gen Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 38,543

Read SEC document
January 26, 2021 Filed Jan 29, 2021 01:08 UTC
Pletcher Brett AEVP,Corp Affairs & Gen Counsel
GrantCommon Stock 13,447 $0.00 $0.00
Disclosure

SEC source: 0001127602-21-002920 · form4.xml · nonDerivative · entry 2

Pletcher Brett A · CIK 0001739307 · EVP,Corp Affairs & Gen Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 42,279

F2 · shares: Represents shares of the Issuer's common stock subject to specific tranches of the performance share award made to the Reporting Person on February 1, 2018. Such tranches of shares were subject to performance-vesting and service-vesting requirements and became issuable on the date reported in Column 2 above upon certification of performance goal attainment by the Compensation and Talent Committee of the Issuer's Board of Directors.

Read SEC document
January 26, 2021 Filed Jan 29, 2021 01:08 UTC
Pletcher Brett AEVP,Corp Affairs & Gen Counsel
GrantCommon Stock 14,188 $0.00 $0.00
Disclosure

SEC source: 0001127602-21-002920 · form4.xml · nonDerivative · entry 1

Pletcher Brett A · CIK 0001739307 · EVP,Corp Affairs & Gen Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 28,832

F1 · shares: Represents shares of the Issuer's common stock subject to specific tranches of the performance share awards made to the Reporting Person on February 6, 2019, and March 10, 2020. Such tranches of shares were subject to both performance-vesting and service-vesting requirements. The performance vesting requirement was satisfied on the date reported in Column 2 above upon certification of performance goal attainment by the Compensation and Talent Committee of the Issuer's Board of Directors. However, the shares will not be issued to the Reporting Person until the requisite continuing service requirements are also met.

Read SEC document
January 22, 2021 Filed Jan 25, 2021 18:55 UTC Exercise / conversionNon-qualified Stock Option (Right to Buy) · Derivative 20,282 $0.00 Strike: $20.65 $0.00
Disclosure

SEC source: 0001127602-21-002420 · form4.xml · derivative · entry 2

Lofton Kevin E · CIK 0001468818 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 20,282 shares

Expires 2021-05-12

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: The options vested quarterly over one year and were fully vested on May 12, 2012.

Read SEC document
January 22, 2021 Filed Jan 25, 2021 18:55 UTC Exercise / conversionCommon Stock 20,282 $20.65 $418,721.89
Disclosure

SEC source: 0001127602-21-002420 · form4.xml · nonDerivative · entry 1

Lofton Kevin E · CIK 0001468818 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 74,203

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
December 30, 2020 Filed Jan 4, 2021 18:21 UTC GrantPhantom Stock · Derivative 33.8286 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001127602-21-000082 · form4.xml · derivative · entry 1

Lofton Kevin E · CIK 0001468818 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,852.0483

Underlying: Common Stock · 33.8286 shares

Expires not disclosed

F1 · security: Each share of phantom stock is the economic equivalent of one share of Gilead common stock.

F2 · shares: Phantom shares accrued under dividend equivalent rights, which are settled in shares and distributed with the phantom stock units to which they relate.

F3 · derivative.exercise_date: The shares of phantom stock are fully vested and, at the election of the reporting person, become payable in common stock at a later date identified by the reporting person.

F3 · derivative.expiration_date: The shares of phantom stock are fully vested and, at the election of the reporting person, become payable in common stock at a later date identified by the reporting person.

Read SEC document
December 30, 2020 Filed Jan 4, 2021 18:24 UTC GrantPhantom Stock · Derivative 68.8983 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001127602-21-000084 · form4.xml · derivative · entry 1

Whitley Richard James · CIK 0001441661 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,808.7328

Underlying: Common Stock · 68.8983 shares

Expires not disclosed

F1 · security: Each share of phantom stock is the economic equivalent of one share of Gilead common stock.

F2 · shares: Phantom shares accrued under dividend equivalent rights, which are settled in shares and distributed with the phantom stock units to which they relate.

F3 · derivative.exercise_date: The shares of phantom stock are fully vested and, at the election of the reporting person, become payable in common stock at a later date identified by the reporting person.

F3 · derivative.expiration_date: The shares of phantom stock are fully vested and, at the election of the reporting person, become payable in common stock at a later date identified by the reporting person.

Read SEC document
December 08, 2020 Filed Dec 10, 2020 21:10 UTC GrantRestricted Stock Unit · Derivative 1,041 Not disclosed Not disclosed
Disclosure

SEC source: 0001127602-20-031071 · form4.xml · derivative · entry 2

Bluestone Jeffrey · CIK 0001771814 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,041

Underlying: Common Stock · 1,041 shares

Expires not disclosed

F2 · derivative.exercise_price: Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock.

F2 · price: Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock.

F3 · derivative.exercise_date: 100% of the restricted stock units vest on December 8, 2021.

F3 · derivative.expiration_date: 100% of the restricted stock units vest on December 8, 2021.

Read SEC document
December 08, 2020 Filed Dec 10, 2020 21:10 UTC GrantNon-qualified Stock Option (Right to Buy) · Derivative 5,879 $0.00 Strike: $61.17 $0.00
Disclosure

SEC source: 0001127602-20-031071 · form4.xml · derivative · entry 1

Bluestone Jeffrey · CIK 0001771814 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,879

Underlying: Common Stock · 5,879 shares

Expires 2030-12-08

F1 · derivative.exercise_date: 25% of the shares subject to the option vest on each three-month anniversary measured from December 8, 2020 such that 100% of the shares subject to the option will be fully vested and exercisable on December 8, 2021.

Read SEC document
November 23, 2020 Filed Dec 29, 2020 20:06 UTC GiftCommon Stock 21,720 $0.00 $0.00
Disclosure

SEC source: 0001127602-20-032439 · form4.xml · nonDerivative · entry 1

Lofton Kevin E · CIK 0001468818 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 53,921

F1 · kind: Reflects the gift of common stock to a charitable donor advised fund.

Read SEC document
November 10, 2020 Filed Nov 12, 2020 22:34 UTC
Wilfong Diane E.SVP, Controller & CAO
Exercise / conversionRestricted Stock Unit · Derivative 657 Not disclosed Not disclosed
Disclosure

SEC source: 0001127602-20-028854 · form4.xml · derivative · entry 5

Wilfong Diane E. · CIK 0001374988 · SVP, Controller & CAO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,971

Underlying: Common Stock · 657 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit represents the contingent right to receive one share of the Issuer's common stock.

F1 · price: Each restricted stock unit represents the contingent right to receive one share of the Issuer's common stock.

F3 · derivative.exercise_date: The restricted stock units have a four year vesting schedule. 25% vest on each yearly anniversary of the date of grant until fully vested.

F3 · derivative.expiration_date: The restricted stock units have a four year vesting schedule. 25% vest on each yearly anniversary of the date of grant until fully vested.

Read SEC document
November 10, 2020 Filed Nov 12, 2020 22:34 UTC
Wilfong Diane E.SVP, Controller & CAO
Exercise / conversionRestricted Stock Unit · Derivative 773 Not disclosed Not disclosed
Disclosure

SEC source: 0001127602-20-028854 · form4.xml · derivative · entry 4

Wilfong Diane E. · CIK 0001374988 · SVP, Controller & CAO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,628

Underlying: Common Stock · 773 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit represents the contingent right to receive one share of the Issuer's common stock.

F1 · price: Each restricted stock unit represents the contingent right to receive one share of the Issuer's common stock.

F2 · derivative.exercise_date: The restricted stock units have a three year vesting schedule. 33.33% will vest on each yearly anniversary of the date of grant until fully vested.

F2 · derivative.expiration_date: The restricted stock units have a three year vesting schedule. 33.33% will vest on each yearly anniversary of the date of grant until fully vested.

Read SEC document
November 10, 2020 Filed Nov 12, 2020 22:34 UTC
Wilfong Diane E.SVP, Controller & CAO
Tax withholdingCommon Stock 611 $60.62 $37,038.82
Disclosure

SEC source: 0001127602-20-028854 · form4.xml · nonDerivative · entry 3

Wilfong Diane E. · CIK 0001374988 · SVP, Controller & CAO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,201

Read SEC document
November 10, 2020 Filed Nov 12, 2020 22:34 UTC
Wilfong Diane E.SVP, Controller & CAO
Exercise / conversionCommon Stock 657 Not disclosed Not disclosed
Disclosure

SEC source: 0001127602-20-028854 · form4.xml · nonDerivative · entry 2

Wilfong Diane E. · CIK 0001374988 · SVP, Controller & CAO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,812

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit represents the contingent right to receive one share of the Issuer's common stock.

Read SEC document
November 10, 2020 Filed Nov 12, 2020 22:34 UTC
Wilfong Diane E.SVP, Controller & CAO
Exercise / conversionCommon Stock 773 Not disclosed Not disclosed
Disclosure

SEC source: 0001127602-20-028854 · form4.xml · nonDerivative · entry 1

Wilfong Diane E. · CIK 0001374988 · SVP, Controller & CAO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,155

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit represents the contingent right to receive one share of the Issuer's common stock.

Read SEC document
November 10, 2020 Filed Nov 12, 2020 22:44 UTC
Parsey MerdadChief Medical Officer
Exercise / conversionRestricted Stock Unit · Derivative 5,101 Not disclosed Not disclosed
Disclosure

SEC source: 0001127602-20-028865 · form4.xml · derivative · entry 3

Parsey Merdad · CIK 0001792150 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 24,019

Underlying: Common Stock · 5,101 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock.

F1 · price: Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock.

F2 · derivative.exercise_date: The restricted stock units have a three year vesting schedule. 33.33% will vest on the anniversary of the date of grant until fully vested.

F2 · derivative.expiration_date: The restricted stock units have a three year vesting schedule. 33.33% will vest on the anniversary of the date of grant until fully vested.

Read SEC document
November 10, 2020 Filed Nov 12, 2020 22:44 UTC
Parsey MerdadChief Medical Officer
Tax withholdingCommon Stock 2,416 $60.62 $146,457.92
Disclosure

SEC source: 0001127602-20-028865 · form4.xml · nonDerivative · entry 2

Parsey Merdad · CIK 0001792150 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,685

Read SEC document
November 10, 2020 Filed Nov 12, 2020 22:44 UTC
Parsey MerdadChief Medical Officer
Exercise / conversionCommon Stock 5,101 Not disclosed Not disclosed
Disclosure

SEC source: 0001127602-20-028865 · form4.xml · nonDerivative · entry 1

Parsey Merdad · CIK 0001792150 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,101

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock.

Read SEC document
November 10, 2020 Filed Nov 12, 2020 22:50 UTC
Dickinson Andrew DEVP, Chief Financial Officer
Exercise / conversionRestricted Stock Unit · Derivative 1,913 Not disclosed Not disclosed
Disclosure

SEC source: 0001127602-20-028870 · form4.xml · derivative · entry 5

Dickinson Andrew D · CIK 0001310204 · EVP, Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 32,118

Underlying: Common Stock · 1,913 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit represents the contingent right to receive one share of the Issuer's common stock.

F1 · price: Each restricted stock unit represents the contingent right to receive one share of the Issuer's common stock.

F3 · derivative.exercise_date: The restricted stock units have a four year vesting schedule. 25% vest on the anniversary of the date of grant until fully vested.

F3 · derivative.expiration_date: The restricted stock units have a four year vesting schedule. 25% vest on the anniversary of the date of grant until fully vested.

Read SEC document
November 10, 2020 Filed Nov 12, 2020 22:50 UTC
Dickinson Andrew DEVP, Chief Financial Officer
Exercise / conversionRestricted Stock Unit · Derivative 1,133 Not disclosed Not disclosed
Disclosure

SEC source: 0001127602-20-028870 · form4.xml · derivative · entry 4

Dickinson Andrew D · CIK 0001310204 · EVP, Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 34,031

Underlying: Common Stock · 1,133 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit represents the contingent right to receive one share of the Issuer's common stock.

F1 · price: Each restricted stock unit represents the contingent right to receive one share of the Issuer's common stock.

F2 · derivative.exercise_date: The restricted stock units have a three year vesting schedule. 33.33% will vest on each yearly anniversary of the date of grant until fully vested.

F2 · derivative.expiration_date: The restricted stock units have a three year vesting schedule. 33.33% will vest on each yearly anniversary of the date of grant until fully vested.

Read SEC document
November 10, 2020 Filed Nov 12, 2020 22:50 UTC
Dickinson Andrew DEVP, Chief Financial Officer
Tax withholdingCommon Stock 1,399 $60.62 $84,807.38
Disclosure

SEC source: 0001127602-20-028870 · form4.xml · nonDerivative · entry 3

Dickinson Andrew D · CIK 0001310204 · EVP, Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,286

Read SEC document
November 10, 2020 Filed Nov 12, 2020 22:50 UTC
Dickinson Andrew DEVP, Chief Financial Officer
Exercise / conversionCommon Stock 1,913 Not disclosed Not disclosed
Disclosure

SEC source: 0001127602-20-028870 · form4.xml · nonDerivative · entry 2

Dickinson Andrew D · CIK 0001310204 · EVP, Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,685

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit represents the contingent right to receive one share of the Issuer's common stock.

Read SEC document
November 10, 2020 Filed Nov 12, 2020 22:50 UTC
Dickinson Andrew DEVP, Chief Financial Officer
Exercise / conversionCommon Stock 1,133 Not disclosed Not disclosed
Disclosure

SEC source: 0001127602-20-028870 · form4.xml · nonDerivative · entry 1

Dickinson Andrew D · CIK 0001310204 · EVP, Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,772

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit represents the contingent right to receive one share of the Issuer's common stock.

Read SEC document
November 03, 2020 Filed Nov 5, 2020 22:16 UTC
Mercier JohannaChief Commercial Officer
Tax withholdingCommon Stock 12,282 $58.83 $722,550.06
Disclosure

SEC source: 0001127602-20-028266 · form4.xml · nonDerivative · entry 2

Mercier Johanna · CIK 0001782135 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,906

Read SEC document
November 03, 2020 Filed Nov 5, 2020 22:16 UTC
Mercier JohannaChief Commercial Officer
GrantCommon Stock 26,270 $0.00 $0.00
Disclosure

SEC source: 0001127602-20-028266 · form4.xml · nonDerivative · entry 1

Mercier Johanna · CIK 0001782135 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 30,188

F1 · shares: Issuance of common stock upon vesting of certain performance share awards on November 3, 2020.

Read SEC document
October 22, 2020 Filed Oct 26, 2020 23:12 UTC GrantNon-qualified Stock Option (Right to Buy) · Derivative 7,718 $0.00 Strike: $60.67 $0.00
Disclosure

SEC source: 0001127602-20-027542 · form4.xml · derivative · entry 2

WELTERS ANTHONY · CIK 0001213307 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,718

Underlying: Common Stock · 7,718 shares

Expires 2030-10-22

F3 · derivative.exercise_date: 25% of the shares subject to the option vest on each three-month anniversary measured from October 22, 2020 such that 100% of the shares subject to the option will be fully vested and exercisable on October 22, 2021.

Read SEC document
October 22, 2020 Filed Oct 26, 2020 23:12 UTC GrantRestricted Stock Unit · Derivative 1,368 Not disclosed Not disclosed
Disclosure

SEC source: 0001127602-20-027542 · form4.xml · derivative · entry 1

WELTERS ANTHONY · CIK 0001213307 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,368

Underlying: Common Stock · 1,368 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock.

F1 · price: Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock.

F2 · derivative.exercise_date: 100% of the restricted stock units will vest on October 22, 2021.

F2 · derivative.expiration_date: 100% of the restricted stock units will vest on October 22, 2021.

Read SEC document
October 01, 2020 Filed Oct 5, 2020 23:09 UTC Exercise / conversionPhantom Stock · Derivative 1,434 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001127602-20-026596 · form4.xml · derivative · entry 2

Whitley Richard James · CIK 0001441661 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,739.8344

Underlying: Common Stock · 1,434 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each share of phantom stock is the economic equivalent of one share of Gilead common stock.

F2 · shares: An aggregate of 1434.958608 shares were reported in Table II when the reporting person acquired the phantom shares. The fractional share of 0.958608 was paid out in cash in connection with the conversion into shares of common stock.

F3 · derivative.exercise_date: The shares of phantom stock are fully vested and, at the election of the reporting person, become payable in common stock at a later date identified by the reporting person.

F3 · derivative.expiration_date: The shares of phantom stock are fully vested and, at the election of the reporting person, become payable in common stock at a later date identified by the reporting person.

Read SEC document
October 01, 2020 Filed Oct 5, 2020 23:09 UTC Exercise / conversionCommon Stock 1,434 $0.00 $0.00
Disclosure

SEC source: 0001127602-20-026596 · form4.xml · nonDerivative · entry 1

Whitley Richard James · CIK 0001441661 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 31,122

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each share of phantom stock is the economic equivalent of one share of Gilead common stock.

Read SEC document
September 29, 2020 Filed Oct 1, 2020 21:07 UTC GrantPhantom Stock · Derivative 30.5255 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001127602-20-026041 · form4.xml · derivative · entry 1

Lofton Kevin E · CIK 0001468818 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,818.2197

Underlying: Common Stock · 30.5255 shares

Expires not disclosed

F1 · security: Each share of phantom stock is the economic equivalent of one share of Gilead common stock.

F2 · shares: Phantom shares accrued under dividend equivalent rights, which are settled in shares and distributed with the phantom stock units to which they relate.

F3 · derivative.exercise_date: The shares of phantom stock are fully vested and, at the election of the reporting person, become payable in common stock at a later date identified by the reporting person.

F3 · derivative.expiration_date: The shares of phantom stock are fully vested and, at the election of the reporting person, become payable in common stock at a later date identified by the reporting person.

Read SEC document
September 29, 2020 Filed Oct 1, 2020 21:20 UTC GrantPhantom Stock · Derivative 77.7136 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001127602-20-026051 · form4.xml · derivative · entry 1

Whitley Richard James · CIK 0001441661 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,174.793

Underlying: Common Stock · 77.7136 shares

Expires not disclosed

F1 · security: Each share of phantom stock is the economic equivalent of one share of Gilead common stock.

F2 · shares: Phantom shares accrued under dividend equivalent rights, which are settled in shares and distributed with the phantom stock units to which they relate.

F3 · derivative.exercise_date: The shares of phantom stock are fully vested and, at the election of the reporting person, become payable in common stock at a later date identified by the reporting person.

F3 · derivative.expiration_date: The shares of phantom stock are fully vested and, at the election of the reporting person, become payable in common stock at a later date identified by the reporting person.

Read SEC document
August 17, 2020 Filed Aug 19, 2020 16:53 UTC
Parsey MerdadChief Medical Officer
SaleCommon Stock 182 $68.32 $12,434.24
Disclosure

SEC source: 0001127602-20-023865 · form4.xml · nonDerivative · entry 2

Parsey Merdad · CIK 0001792150 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

F3 · kind: The sale transaction reported on this Form 4 was made pursuant to a Rule 10b5-1 trading plan.

Read SEC document
August 15, 2020 Filed Aug 19, 2020 16:53 UTC
Parsey MerdadChief Medical Officer
GrantCommon Stock 182 $57.43 $10,451.53
Disclosure

SEC source: 0001127602-20-023865 · form4.xml · nonDerivative · entry 1

Parsey Merdad · CIK 0001792150 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 182

F1 · shares: The reporting person is voluntarily reporting the acquisition of shares of the Issuer's common stock pursuant to the Gilead Sciences, Inc. Employee Stock Purchase Plan ("ESPP") for the ESPP purchase period of February 16, 2020 through August 15, 2020. This transaction is exempt under Rule 16b-3(c).

F2 · price: In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the Issuer's stock on February 16, 2020.

Read SEC document
August 10, 2020 Filed Aug 12, 2020 18:59 UTC
Wilfong Diane E.SVP, Controller & CAO
Exercise / conversionRestricted Stock Unit · Derivative 3,345 Not disclosed Not disclosed
Disclosure

SEC source: 0001127602-20-023432 · form4.xml · derivative · entry 3

Wilfong Diane E. · CIK 0001374988 · SVP, Controller & CAO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,401

Underlying: Common Stock · 3,345 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit represents the contingent right to receive one share of the Issuer's common stock.

F1 · price: Each restricted stock unit represents the contingent right to receive one share of the Issuer's common stock.

F2 · derivative.exercise_date: The restricted stock units have a three year vesting schedule. 33.33% will vest on each yearly anniversary of the date of grant until fully vested.

F2 · derivative.expiration_date: The restricted stock units have a three year vesting schedule. 33.33% will vest on each yearly anniversary of the date of grant until fully vested.

Read SEC document
August 10, 2020 Filed Aug 12, 2020 18:59 UTC
Wilfong Diane E.SVP, Controller & CAO
Tax withholdingCommon Stock 1,384 $68.51 $94,817.84
Disclosure

SEC source: 0001127602-20-023432 · form4.xml · nonDerivative · entry 2

Wilfong Diane E. · CIK 0001374988 · SVP, Controller & CAO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,382

Read SEC document
August 10, 2020 Filed Aug 12, 2020 18:59 UTC
Wilfong Diane E.SVP, Controller & CAO
Exercise / conversionCommon Stock 3,345 Not disclosed Not disclosed
Disclosure

SEC source: 0001127602-20-023432 · form4.xml · nonDerivative · entry 1

Wilfong Diane E. · CIK 0001374988 · SVP, Controller & CAO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,766

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit represents the contingent right to receive one share of the Issuer's common stock.

Read SEC document
August 10, 2020 Filed Aug 12, 2020 20:57 UTC
Dickinson Andrew DEVP, Chief Financial Officer
Exercise / conversionRestricted Stock Unit · Derivative 2,306 Not disclosed Not disclosed
Disclosure

SEC source: 0001127602-20-023463 · form4.xml · derivative · entry 3

Dickinson Andrew D · CIK 0001310204 · EVP, Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 35,164

Underlying: Common Stock · 2,306 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit represents the contingent right to receive one share of the Issuer's common stock.

F1 · price: Each restricted stock unit represents the contingent right to receive one share of the Issuer's common stock.

F2 · derivative.exercise_date: The restricted stock units have a three year vesting schedule. 33.33% will vest on each yearly anniversary of the date of grant until fully vested.

F2 · derivative.expiration_date: The restricted stock units have a three year vesting schedule. 33.33% will vest on each yearly anniversary of the date of grant until fully vested.

Read SEC document
August 10, 2020 Filed Aug 12, 2020 20:57 UTC
Dickinson Andrew DEVP, Chief Financial Officer
Tax withholdingCommon Stock 1,022 $68.51 $70,017.22
Disclosure

SEC source: 0001127602-20-023463 · form4.xml · nonDerivative · entry 2

Dickinson Andrew D · CIK 0001310204 · EVP, Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,639

Read SEC document
August 10, 2020 Filed Aug 12, 2020 20:57 UTC
Dickinson Andrew DEVP, Chief Financial Officer
Exercise / conversionCommon Stock 2,306 Not disclosed Not disclosed
Disclosure

SEC source: 0001127602-20-023463 · form4.xml · nonDerivative · entry 1

Dickinson Andrew D · CIK 0001310204 · EVP, Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,661

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit represents the contingent right to receive one share of the Issuer's common stock.

Read SEC document
July 24, 2020 Filed Jul 28, 2020 22:47 UTC
Mercier JohannaChief Commercial Officer
Exercise / conversionRestricted Stock Unit · Derivative 7,505 $0.00 $0.00
Disclosure

SEC source: 0001127602-20-022184 · form4.xml · derivative · entry 3

Mercier Johanna · CIK 0001782135 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 34,615

Underlying: Common Stock · 7,505 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit represents the contingent right to receive one share of the Issuer's common stock.

F2 · derivative.exercise_date: The restricted stock units have a four- year vesting schedule. 25% vest on each yearly anniversary of the date of grant until fully vested.

F2 · derivative.expiration_date: The restricted stock units have a four- year vesting schedule. 25% vest on each yearly anniversary of the date of grant until fully vested.

Read SEC document
July 24, 2020 Filed Jul 28, 2020 22:47 UTC
Mercier JohannaChief Commercial Officer
Tax withholdingCommon Stock 3,587 $73.64 $264,146.68
Disclosure

SEC source: 0001127602-20-022184 · form4.xml · nonDerivative · entry 2

Mercier Johanna · CIK 0001782135 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,918

Read SEC document
July 24, 2020 Filed Jul 28, 2020 22:47 UTC
Mercier JohannaChief Commercial Officer
Exercise / conversionCommon Stock 7,505 $0.00 $0.00
Disclosure

SEC source: 0001127602-20-022184 · form4.xml · nonDerivative · entry 1

Mercier Johanna · CIK 0001782135 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,505

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
June 29, 2020 Filed Jul 1, 2020 20:55 UTC GrantPhantom Stock · Derivative 25.1945 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001127602-20-020665 · form4.xml · derivative · entry 1

Lofton Kevin E · CIK 0001468818 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,787.6942

Underlying: Common Stock · 25.1945 shares

Expires not disclosed

F1 · security: Each share of phantom stock is the economic equivalent of one share of Gilead common stock.

F2 · shares: Phantom shares accrued under dividend equivalent rights, which are settled in shares and distributed with the phantom stock units to which they relate.

F3 · derivative.exercise_date: The shares of phantom stock are fully vested and, at the election of the reporting person, become payable in common stock at a later date identified by the reporting person.

F3 · derivative.expiration_date: The shares of phantom stock are fully vested and, at the election of the reporting person, become payable in common stock at a later date identified by the reporting person.

Read SEC document
June 29, 2020 Filed Jul 1, 2020 21:03 UTC GrantPhantom Stock · Derivative 64.1416 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001127602-20-020666 · form4.xml · derivative · entry 1

Whitley Richard James · CIK 0001441661 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,097.0794

Underlying: Common Stock · 64.1416 shares

Expires not disclosed

F1 · security: Each share of phantom stock is the economic equivalent of one share of Gilead common stock.

F2 · shares: Phantom shares accrued under dividend equivalent rights, which are settled in shares and distributed with the phantom stock units to which they relate.

F3 · derivative.exercise_date: The shares of phantom stock are fully vested and, at the election of the reporting person, become payable in common stock at a later date identified by the reporting person.

F3 · derivative.expiration_date: The shares of phantom stock are fully vested and, at the election of the reporting person, become payable in common stock at a later date identified by the reporting person.

Read SEC document
June 23, 2020 Filed Jun 25, 2020 17:51 UTC SaleCommon Stock 189 $75.50 $14,269.50
Disclosure

SEC source: 0001127602-20-020353 · form4.xml · nonDerivative · entry 1

Rodriguez Javier · CIK 0001415548 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.